Methyl 2,2,2-trichloroacetimidate → 4-(2-Ethoxy-ethoxy)-2-trichloromethyl-1H-benzoimidazole

HRID 18600

반응식

HRID 18600 반응식
[CH2:1]([O:3][CH2:4][CH2:5][O:6][C:7]1[CH:12]=[CH:11][CH:10]=[C:9]([NH2:13])[C:8]=1[NH2:14])[CH3:2].CO[C:17](=N)[C:18]([Cl:21])([Cl:20])[Cl:19]>>[CH2:1]([O:3][CH2:4][CH2:5][O:6][C:7]1[C:8]2[N:14]=[C:17]([C:18]([Cl:21])([Cl:20])[Cl:19])[NH:13][C:9]=2[CH:10]=[CH:11][CH:12]=1)[CH3:2]

참가 물질

3

실험 절차

4-(2-Ethoxy-ethoxy)-2-trichloromethyl-1H-benzoimidazole was prepared by a procedure according to example 108 (iii) starting from 345 mg (1.76 mmol) 3-(2-Ethoxy-ethoxy)-benzene-1,2-diamine and 0.30 mL (2.46 mmol) 2,2,2-trichloro-acetimidic acid methyl ester.

출처 및 근거

ORD 기록
ord-e868a212e39a4faaa9e5289325dfabb9
출처 데이터셋
uspto-grants-2010_06
특허 번호
US07741341B2

연결된 노트

불러오는 중…